Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05541497 · ClinicalTrials.gov registry record · Phase 2

Varenicline for Treatment of E-cigarette Dependence

A Phase 2 study of Smoking Cessation, sponsored by Yale University.

Completed
Registry status
Phase 2
Development phase
40
Enrollment target
2
Study locations

NCT05541497 is a Phase 2 study of Smoking Cessation that has completed, run by Yale University. The registered enrollment target is 40 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05541497, a Phase 2 study of Smoking Cessation, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 2
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

Varenicline is used to treat tobacco use dependence. It helps reduce cravings for tobacco use and decreases the pleasurable effects of cigarettes and other tobacco products. Varenicline has been proven to reduce the desire to smoke cigarettes. This study aims to test whether it shows a similar benefit for individuals who vape and are interested in quitting.

Conditions Studied

Smoking Cessation

Interventions

  • DRUG Placebo
  • DRUG Varenicline Tartrate

Study Locations (2)

Connecticut

  • Yale University - New Haven

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-11-04
Est. Completion 2023-09-01
Phase Phase 2

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05541497

The ClinicalTrials.gov registry entry for NCT05541497 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (92% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05541497 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, South Carolina.

Frequently Asked Questions

What is clinical trial NCT05541497 about?

NCT05541497 is a clinical study titled "Varenicline for Treatment of E-cigarette Dependence". Varenicline is used to treat tobacco use dependence. It helps reduce cravings for tobacco use and decreases the pleasurable effects of cigarettes and other tobacco products. Varenicline has been proven to reduce the desire to smoke cigarettes. This study aims to test whether it shows a similar benef...

What is the current status of trial NCT05541497?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2022-11-04. Estimated completion is 2023-09-01.

What conditions does trial NCT05541497 study?

This clinical trial studies the following conditions: Smoking Cessation.

What interventions are being tested in trial NCT05541497?

The interventions under investigation include: Placebo (DRUG), Varenicline Tartrate (DRUG).

Who is sponsoring clinical trial NCT05541497?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05541497 being conducted?

This trial has 2 study locations across Connecticut, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Smoking Cessation

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.